CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN CONTINGENTLY REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ (DEFICIT) EQUITY - USD ($)	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2020	504,000,000
Beginning balance at Dec. 31, 2020	$ 5,244,000,000
Contingently Redeemable Convertible Preferred Stock
Capital stock issuance (in shares)	72,000,000
Capital stock issuance	$ 2,650,000,000
Ending balance (in shares) at Mar. 31, 2021	576,000,000
Ending balance at Mar. 31, 2021	$ 7,894,000,000
Beginning balance (in shares) at Dec. 31, 2020		101,000,000
Beginning balance at Dec. 31, 2020	(1,384,000,000)	$ 0	$ 302,000,000	$ (1,686,000,000)	$ 0
Stockholders' (Deficit) Equity
Capital stock issuance	1,000,000		1,000,000
Net loss	(414,000,000)			(414,000,000)
Ending balance (in shares) at Mar. 31, 2021		101,000,000
Ending balance at Mar. 31, 2021	$ (1,797,000,000)	$ 0	303,000,000	(2,100,000,000)	0
Beginning balance (in shares) at Dec. 31, 2020	504,000,000
Beginning balance at Dec. 31, 2020	$ 5,244,000,000
Ending balance (in shares) at Sep. 30, 2021	576,000,000
Ending balance at Sep. 30, 2021	$ 7,894,000,000
Beginning balance (in shares) at Dec. 31, 2020		101,000,000
Beginning balance at Dec. 31, 2020	(1,384,000,000)	$ 0	302,000,000	(1,686,000,000)	0
Stockholders' (Deficit) Equity
Other comprehensive loss	0
Net loss	(2,227,000,000)
Ending balance (in shares) at Sep. 30, 2021		102,000,000
Ending balance at Sep. 30, 2021	$ (3,607,000,000)	$ 0	306,000,000	(3,913,000,000)	0
Beginning balance (in shares) at Mar. 31, 2021	576,000,000
Beginning balance at Mar. 31, 2021	$ 7,894,000,000
Ending balance (in shares) at Jun. 30, 2021	576,000,000
Ending balance at Jun. 30, 2021	$ 7,894,000,000
Beginning balance (in shares) at Mar. 31, 2021		101,000,000
Beginning balance at Mar. 31, 2021	(1,797,000,000)	$ 0	303,000,000	(2,100,000,000)	0
Stockholders' (Deficit) Equity
Capital stock issuance	2,000,000		2,000,000
Net loss	(580,000,000)			(580,000,000)
Ending balance (in shares) at Jun. 30, 2021		101,000,000
Ending balance at Jun. 30, 2021	$ (2,375,000,000)	$ 0	305,000,000	(2,680,000,000)	0
Ending balance (in shares) at Sep. 30, 2021	576,000,000
Ending balance at Sep. 30, 2021	$ 7,894,000,000
Stockholders' (Deficit) Equity
Capital stock issuance (in shares)		1,000,000
Capital stock issuance	1,000,000		1,000,000
Other comprehensive loss	0
Net loss	(1,233,000,000)			(1,233,000,000)
Ending balance (in shares) at Sep. 30, 2021		102,000,000
Ending balance at Sep. 30, 2021	$ (3,607,000,000)	$ 0	306,000,000	(3,913,000,000)	0
Beginning balance (in shares) at Dec. 31, 2021	0
Beginning balance at Dec. 31, 2021	$ 0
Ending balance (in shares) at Mar. 31, 2022	0
Ending balance at Mar. 31, 2022	$ 0
Beginning balance (in shares) at Dec. 31, 2021	900,000,000	900,000,000
Beginning balance at Dec. 31, 2021	$ 19,514,000,000	$ 1,000,000	25,887,000,000	(6,374,000,000)	0
Stockholders' (Deficit) Equity
Capital stock issuance (in shares)		1,000,000
Capital stock issuance	1,000,000		1,000,000
Stock-based compensation	338,000,000		338,000,000
Net loss	(1,593,000,000)			(1,593,000,000)
Ending balance (in shares) at Mar. 31, 2022		901,000,000
Ending balance at Mar. 31, 2022	$ 18,260,000,000	$ 1,000,000	26,226,000,000	(7,967,000,000)	0
Beginning balance (in shares) at Dec. 31, 2021	0
Beginning balance at Dec. 31, 2021	$ 0
Ending balance (in shares) at Sep. 30, 2022	0
Ending balance at Sep. 30, 2022	$ 0
Beginning balance (in shares) at Dec. 31, 2021	900,000,000	900,000,000
Beginning balance at Dec. 31, 2021	$ 19,514,000,000	$ 1,000,000	25,887,000,000	(6,374,000,000)	0
Stockholders' (Deficit) Equity
Other comprehensive loss	(4,000,000)
Net loss	$ (5,029,000,000)
Ending balance (in shares) at Sep. 30, 2022	921,000,000	921,000,000
Ending balance at Sep. 30, 2022	$ 15,337,000,000	$ 1,000,000	26,743,000,000	(11,403,000,000)	(4,000,000)
Beginning balance (in shares) at Mar. 31, 2022	0
Beginning balance at Mar. 31, 2022	$ 0
Ending balance (in shares) at Jun. 30, 2022	0
Ending balance at Jun. 30, 2022	$ 0
Beginning balance (in shares) at Mar. 31, 2022		901,000,000
Beginning balance at Mar. 31, 2022	18,260,000,000	$ 1,000,000	26,226,000,000	(7,967,000,000)	0
Stockholders' (Deficit) Equity
Capital stock issuance (in shares)		15,000,000
Capital stock issuance	57,000,000		57,000,000
Stock-based compensation	264,000,000		264,000,000
Other comprehensive loss	(1,000,000)				(1,000,000)
Net loss	(1,712,000,000)			(1,712,000,000)
Ending balance (in shares) at Jun. 30, 2022		916,000,000
Ending balance at Jun. 30, 2022	$ 16,868,000,000	$ 1,000,000	26,547,000,000	(9,679,000,000)	(1,000,000)
Ending balance (in shares) at Sep. 30, 2022	0
Ending balance at Sep. 30, 2022	$ 0
Stockholders' (Deficit) Equity
Capital stock issuance (in shares)		5,000,000
Capital stock issuance	7,000,000		7,000,000
Stock-based compensation	189,000,000		189,000,000
Other comprehensive loss	(3,000,000)				(3,000,000)
Net loss	$ (1,724,000,000)			(1,724,000,000)
Ending balance (in shares) at Sep. 30, 2022	921,000,000	921,000,000
Ending balance at Sep. 30, 2022	$ 15,337,000,000	$ 1,000,000	$ 26,743,000,000	$ (11,403,000,000)	$ (4,000,000)